{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:43:09Z","timestamp":1778859789154,"version":"3.51.4"},"reference-count":46,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["obgyn.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJOG"],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>To develop target product profiles (TPPs) for new medicines for preterm birth prevention and preterm labour management that address the real\u2010world need of women and healthcare providers, informed by views and agreement amongst globally diverse stakeholders.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>Mixed methods.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting<\/jats:title><jats:p>Global (with a focus on low\u2010 and middle\u2010income countries, LMICs).<\/jats:p><\/jats:sec><jats:sec><jats:title>Sample<\/jats:title><jats:p>Global stakeholders with diverse expertise in preterm labour\/birth and drug development.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Following an initial literature review, diverse stakeholders were invited to participate in an online international survey and in\u2010depth interviews. The level of stakeholder agreement with TPPs was assessed, and findings from interviews were synthesised to inform the final TPPs.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcomes measures<\/jats:title><jats:p>Level of stakeholder agreement on the minimum and preferred requirements for preterm labour\/birth medicines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We performed 21 interviews. Interview participants demonstrated strong agreement on room temperature stability, no additional drug\u2010specific clinical monitoring, and affordability in LMICs being the minimal acceptable requirements. Points of discussion were raised around the target population. Survey respondents included clinicians, researchers, funding agency staff, international public organisation staff, programme implementers, policymakers, representatives of consumer advocacy organisations and other relevant stakeholders from maternal health systems. Survey results indicated strong agreement amongst stakeholders, with only one variable in each TPP not reaching consensus (i.e. 25% disagree or strongly disagree).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>There is strong consensus within the preterm labour\/birth community on the characteristics that new medicines for preterm birth prevention and preterm labour management must achieve. These TPPs provide necessary guidance to evaluate new candidates and their potential for implementation in a range of settings.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1471-0528.17314","type":"journal-article","created":{"date-parts":[[2022,10,9]],"date-time":"2022-10-09T12:04:35Z","timestamp":1665317075000},"page":"71-80","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Expert consensus on novel medicines to prevent preterm birth and manage preterm labour: Target product profiles"],"prefix":"10.1111","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1182-6679","authenticated-orcid":false,"given":"Annie R. A.","family":"McDougall","sequence":"first","affiliation":[{"name":"Maternal, Child and Adolescent Health Program, Burnet Institute  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Tuttle","sequence":"additional","affiliation":[{"name":"Policy Cures Research  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maya","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Policy Cures Research  Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Ammerdorffer","sequence":"additional","affiliation":[{"name":"Concept Foundation  Geneva Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lily","family":"Aboud","sequence":"additional","affiliation":[{"name":"Maternal, Child and Adolescent Health Program, Burnet Institute  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4674-0998","authenticated-orcid":false,"given":"Ahmet M.","family":"G\u00fclmezoglu","sequence":"additional","affiliation":[{"name":"Concept Foundation  Geneva Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua P.","family":"Vogel","sequence":"additional","affiliation":[{"name":"Maternal, Child and Adolescent Health Program, Burnet Institute  Melbourne Victoria Australia"},{"name":"School of Public Health and Preventive Medicine Monash University  Melbourne Victoria Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4755-11-82"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(18)30451-0"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2016.4805"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.10244"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.12631"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(08)60074-4"},{"key":"e_1_2_11_8_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-064547","article-title":"Interventions to prevent spontaneous preterm birth in women with singleton pregnancy who are at high risk: systematic review and network meta\u2010analysis","volume":"376","author":"Care A","year":"2022","journal-title":"BMJ"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00217-8"},{"key":"e_1_2_11_10_1","unstructured":"WHO recommendations on interventions to improve preterm birth outcomes. Geneva: Switzerland; 2015."},{"issue":"8","key":"e_1_2_11_11_1","article-title":"Tocolytics for delaying preterm birth: a network meta\u2010analysis (0924)","author":"Wilson A","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_11_12_1","unstructured":"WHO UNICEF UNFPA Group WB UN.Trends in maternal mortality 2000 to 2017: estimates by WHO UNICEF UNFPA World Bank Group and the United Nations Population Division. Geneva: WHO; 2019."},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)01112-0"},{"key":"e_1_2_11_14_1","unstructured":"WHO.Newborn mortality Geneva; Switzerland2022.Available from:https:\/\/www.who.int\/news\u2010room\/fact\u2010sheets\/detail\/levels\u2010and\u2010trends\u2010in\u2010child\u2010mortality\u2010report\u20102021."},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050022"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(20)30234-4"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0228311"},{"key":"e_1_2_11_18_1","unstructured":"Food and Drug Administration.Guidance for industry and review staff target product profile \u2014 a strategic development process tool (Draft Guidance).2007."},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0237424"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-002067"},{"key":"e_1_2_11_21_1","unstructured":"WHO.TDR: For research on diseases of poverty. Health Product Profile Directory 2021. Available from:https:\/\/www.who.int\/tdr\/diseases\u2010topics\/product\u2010directory\/en\/."},{"key":"e_1_2_11_22_1","unstructured":"WHO.Target product profiles for needed antibacterial agents: enteric fever gonorrhoea neonatal sepsis urinary tract infections and meeting report. Geneva: World Health Organisation; 2020. Contract No.: Licence: CC BY\u2010NC\u2010SA 3.0 IGO."},{"key":"e_1_2_11_23_1","unstructured":"UNICEF NEST360.Target product profiles for newborn care in low\u2010resource settings (v1.2): consensus meeting report March 2020.2020."},{"key":"e_1_2_11_24_1","unstructured":"Concept Foundation.Accelerating innovation for mothers: target product profiles Geneva Switzerland: Concept Foundation;2021. Available from:https:\/\/www.conceptfoundation.org\/accelerating\u2010innovation\u2010for\u2010mothers\/target\u2010product\u2010profiles\/"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01582-1"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2019-001683"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60686-8"},{"key":"e_1_2_11_28_1","first-page":"25","article-title":"Effects of antenatal dexamethasone on respiratory distress in late preterm infant: a randomized controlled trial","volume":"23","author":"Attawattanakul NPT","year":"2015","journal-title":"Thai J Obstet Gynaecol"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/tropej\/fmy001"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d1696"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(21)00178-9"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-014-0072-x"},{"key":"e_1_2_11_33_1","unstructured":"BhattacharyaS Innovation BHPCfRSa.Safe and effective medicines for use in pregnancy: a call to action. University of Birmingham; Birmingham UK; 2021."},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30163-9"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13690-021-00708-y"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2020.07.058"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.015302"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15173"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2022.01.006"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-018-2078-5"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318176158e"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13852"},{"key":"e_1_2_11_43_1","unstructured":"RANZCOG.Progesterone: use in the second and third trimester of pregnancy for the prevention of preterm birth. Melbourne Australia; 2017."},{"key":"e_1_2_11_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004479"},{"key":"e_1_2_11_45_1","unstructured":"U.S. Food and Drug Administration.CDER proposes withdrawal of approval for Makena 2020. Available from:https:\/\/www.fda.gov\/drugs\/drug\u2010safety\u2010and\u2010availability\/cder\u2010proposes\u2010withdrawal\u2010approval\u2010makena"},{"key":"e_1_2_11_46_1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10132912"},{"key":"e_1_2_11_47_1","unstructured":"Foundation C.Medicines for pregnancy specific conditions: research development and market analysis 2021. Available from:https:\/\/www.conceptfoundation.org\/global\u2010news\/medicines\u2010for\u2010pregnancy\u2010specific\u2010conditions\u2010research\u2010development\u2010and\u2010market\u2010analysis\/"}],"container-title":["BJOG: An International Journal of Obstetrics &amp; Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1471-0528.17314","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/1471-0528.17314","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1471-0528.17314","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T08:34:29Z","timestamp":1702974869000},"score":1,"resource":{"primary":{"URL":"https:\/\/obgyn.onlinelibrary.wiley.com\/doi\/10.1111\/1471-0528.17314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["10.1111\/1471-0528.17314"],"URL":"https:\/\/doi.org\/10.1111\/1471-0528.17314","archive":["Portico"],"relation":{},"ISSN":["1470-0328","1471-0528"],"issn-type":[{"value":"1470-0328","type":"print"},{"value":"1471-0528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]},"assertion":[{"value":"2022-05-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-10-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}